Literature DB >> 2801982

Effects of vasopressin on pulmonary and systemic vascular mechanics.

A W Wallace1, C M Tunin, A A Shoukas.   

Abstract

The direct effects of vasopressin on the resistance and capacitance properties of the pulmonary and systemic vasculature were studied in nine aneural dogs on systemic and pulmonary bypass. The systemic and pulmonary pressure-flow, the systemic and pulmonary arterial pressure-volume, and the systemic and pulmonary venous pressure-volume relationships were determined for five levels of infused vasopressin. Vasopressin levels of approximately 10, 30, 150, 300, and 500 pg/ml were achieved by intravenous infusions. Samples of venous blood were drawn before and after each set of pressure-flow and pressure-volume relationships for the determination of vasopressin level by radioimmunoassay. A linear relationship was found between vasopressin level and systemic vascular resistance. Systemic vascular resistance increased 0.072 +/- 0.011 mmHg.kg.min.ml-1 for a change in vasopressin level of 100 pg/ml. Vasopressin did not affect pulmonary vascular resistance or any vascular compliance. High doses of infused arginine vasopressin were necessary to elicit substantial vasoconstriction.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2801982     DOI: 10.1152/ajpheart.1989.257.4.H1228

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  8 in total

1.  Vasopressin or norepinephrine in early hyperdynamic septic shock: a randomized clinical trial.

Authors:  François Lauzier; Bruno Lévy; Patrice Lamarre; Olivier Lesur
Journal:  Intensive Care Med       Date:  2006-09-22       Impact factor: 17.440

Review 2.  Management of vasodilatory shock: defining the role of arginine vasopressin.

Authors:  Martin W Dunser; Volker Wenzel; Andreas J Mayr; Walter R Hasibeder
Journal:  Drugs       Date:  2003       Impact factor: 9.546

Review 3.  Role of vasopressin in the management of septic shock.

Authors:  Gökhan M Mutlu; Phillip Factor
Journal:  Intensive Care Med       Date:  2004-04-21       Impact factor: 17.440

Review 4.  Hyponatremia in patients with heart failure.

Authors:  Theodosios D Filippatos; Moses S Elisaf
Journal:  World J Cardiol       Date:  2013-09-26

5.  Terlipressin versus norepinephrine to prevent milrinone-induced systemic vascular hypotension in cardiac surgery patient with pulmonary hypertension.

Authors:  Mai Mohsen Abdelazziz; Hadil Magdi Abdelhamid
Journal:  Ann Card Anaesth       Date:  2019 Apr-Jun

Review 6.  Vasopressors for the Treatment and Prophylaxis of Spinal Induced Hypotension during Caesarean Section.

Authors:  Ebru Biricik; Hakkı Ünlügenç
Journal:  Turk J Anaesthesiol Reanim       Date:  2020-05-05

Review 7.  Arterial pulmonary hypertension in noncardiac intensive care unit.

Authors:  Mykola V Tsapenko; Arseniy V Tsapenko; Thomas Bo Comfere; Girish K Mour; Sunil V Mankad; Ognjen Gajic
Journal:  Vasc Health Risk Manag       Date:  2008

8.  Unpredictable nature of tolvaptan in treatment of hypervolemic hyponatremia: case review on role of vaptans.

Authors:  Ishan Malhotra; Shilpa Gopinath; Kalyana C Janga; Sheldon Greenberg; Shree K Sharma; Regina Tarkovsky
Journal:  Case Rep Endocrinol       Date:  2014-01-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.